United States President Joe Biden has vetoed a resolution that would have overruled the U.S. Securities and Exchange CommissionJoe Biden has vetoed a resolution that would have overruled the U.S. Securities and Exchange Commission (SEC) Staff Accounting Bulletin (SAB) No. 121. The controversial decision was immediately met with criticism from the cryptocurrency industry.
Saturday, June 01, 2024
Biden Hates Innovation
Sunday, May 19, 2024
Illegal Invaders Are Great Swimmers
Mayor Adams calls migrants ‘excellent swimmers,’ possible lifeguards
Tuesday, April 16, 2024
Pfizer's Emergency Medicine Proved Useless Two Years Ago
The drug companies like Pfizer and prescribing doctors made a lot of money on this worthless treatment. In December 2021 the FDA's Patrizia Cavazzoni turned on the money hose for Pfizer.
Coronavirus (COVID-19) Update: FDA Authorizes First Oral Antiviral for Treatment of COVID-19
U.S. Food and Drug Administration issued an emergency use authorization (EUA) for Pfizer’s Paxlovid (nirmatrelvir tablets and ritonavir tablets, co-packaged for oral use) for the treatment of mild-to-moderate coronavirus disease (COVID-19) in adults and pediatric patients ...
“Today’s authorization introduces the first treatment for COVID-19 that is in the form of a pill that is taken orally — a major step forward in the fight against this global pandemic,” said Patrizia Cavazzoni, M.D., director of the FDA’s Center for Drug Evaluation and Research.
In April 2024 the New England Journal of Medicine published a report which showed the Paxlovid drug was useless in treating Covid.
Nirmatrelvir for Vaccinated or Unvaccinated Adult Outpatients with Covid-19
Among the 1288 participants who received at least one dose of nirmatrelvir–ritonavir or placebo and had at least one postbaseline visit, the median time to sustained alleviation of all targeted Covid-19 signs or symptoms through day 28 was 12 days in the nirmatrelvir–ritonavir group and 13 days in the placebo group, a difference that was not significant (P=0.60).
...
From August 25, 2021, to July 25, 2022, a total of 1296 participants underwent randomization and were included in the full analysis population (Figure 1), and 1288 received at least one dose of nirmatrelvir–ritonavir (654 participants) or placebo (634 participants) and had at least one postbaseline visit.
The study was run in 2021 into mid-2022. The results were available later in 2022 to show that Pfizer's Paxlovid did not work for treating Covid. The FDA has not updated the press release of their emergency use authorization, and has not apologized for giving false hope to those suffering Covid. Why were the results of the study not published for NEARLY TWO YEARS? During the past two years Pfizer continued to be paid for a treatment that does not work. The FDA should be reprimanded and lose some funding.
Thursday, February 22, 2024
Worldwide Bankers Hate The People's Money
The European Central Bank, in an article authored by Ulrich Bindseil and Jürgen Schaaf, declare Bitcoin a failure. If people create and use their own money as a store of value and medium of exchange, the ECB will find it difficult to run endless inflation.
They say, "... the fair value of Bitcoin is still zero." The value of the euro will trend to zero and the Europeans will do their frequent currency cancellation when moving to a digital state-controlled currency. In the meantime, Ulrich and Jürgen will try to hold on to their taxpayer-funded jobs a little longer.